• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. G2 EXPRESS FILTER SYST - FEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. G2 EXPRESS FILTER SYST - FEM; VENA CAVA FILTER Back to Search Results
Catalog Number RF400F
Device Problem Obstruction of Flow (2423)
Patient Problems Edema (1820); Occlusion (1984); Pain (1994)
Event Date 08/14/2015
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Medical record review: a vena cava filter was deployed for a preoperative diagnosis of deep vein thrombosis and gastric bypass surgery.The deployed filter was successfully placed infrarenal via the right common femoral vein after an attempted placement in the right common iliac vein.Attempted placement was terminated due to the filter coiling up several times in the right groin due to body habitus.Inferior venacavogram performed during filter deployment revealed the inferior vena cava diameter to be 22 mm.Patient tolerated the successful placement procedure without complications.Approximately six years post deployment, a venogram was performed indicating patency of the left femoral and popliteal veins, normal flow in to the left iliac veins with an occlusion in the ivc at the level of the filter with extension into the left common iliac vein.Approximate sixteen days later, the patient presented for filter removal via the right internal jugular vein.Venograms indicated the ivc to be occluded, right iliac and right common iliac veins demonstrated webs and chronic occlusive disease.The filter was snared with a gooseneck snare and spectranetics glidelite laser sheath.Ivc filter removed with assisted endovascular laser.Right common iliac vein was stenosed and dilated with a mustang balloon.Filter was inspected and found to be intact.Venogram demonstrated a small amount pericaval extravasation which appeared not clinically significant.Investigation summary: the device was not returned for evaluation.Images were not provided for review.Medical records were provided and reviewed.Approximately six years post deployment, a venogram indicated an occlusion in the ivc at the level of the filter with extension into the left common iliac vein.Therefore, the investigation is confirmed for occlusion of the filter.Based upon the available information, the definitive root cause is unknown.Labeling review: the current ifu (instructions for use) states: precautions: the safety and effectiveness of this device has not been established for morbidly obese patients.Open abdominal procedures such as bariatric surgery may affect the integrity and stability of the filter a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date: 10/2011); (manufacturing date: 10/2008).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient in conjunction with or before bariatric procedure.At some time post filter deployment, it was alleged that the patient experienced deep vein thrombosis, vein occlusion with extensive fibrous web development, pelvic venous obstruction, and complex laser assisted removal of indwelling ivc filter with angioplasty.Furthermore, it was alleged that the patient also experienced a vein stenting procedure, pain, edema, and other continuing sequelae.The device was removed percutaneously.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G2 EXPRESS FILTER SYST - FEM
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key8048288
MDR Text Key126503042
Report Number2020394-2018-01993
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K080668
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 11/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/07/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRF400F
Device Lot NumberGFSI2315
Was Device Available for Evaluation? No
Date Manufacturer Received10/15/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age53 YR
Patient Weight173
-
-